Part 3: Key Takeaways from Claim Examples in the 2024 AI Patent Eligibility Guidance

Part 3 This is the third post in a 3-part series. Below, we describe Example 49 which focuses on using AI to assist with a medical treatment. Example 49. Fibrosis Treatment Key Takeaway for Claim 1: Example 49, Claim 1 includes a likely split-actor issue, because the entities collecting the sample, identifying the high risk/weighted …